Mizokami A - Search Results

1

Cyclooxygenase-2 promotes prostate cancer progression.

Fujita H, Koshida K, Keller ET, Takahashi Y, Yoshimito T, Namiki M, Mizokami A. Fujita H, et al. Among authors: mizokami a. Prostate. 2002 Nov 1;53(3):232-40. doi: 10.1002/pros.10152. Prostate. 2002. PMID: 12386924

2

Regulation of androgen receptor by androgen and epidermal growth factor in a human prostatic cancer cell line, LNCaP.

Mizokami A, Saiga H, Matsui T, Mita T, Sugita A. Mizokami A, et al. Endocrinol Jpn. 1992 Jun;39(3):235-43. doi: 10.1507/endocrj1954.39.235. Endocrinol Jpn. 1992. PMID: 1425449 Free article.

3

Inhibition of growth and increase of acid phosphatase by testosterone on androgen-independent murine prostatic cancer cells transfected with androgen receptor cDNA.

Suzuki H, Nihei N, Sato N, Ichikawa T, Mizokami A, Shimazaki J. Suzuki H, et al. Among authors: mizokami a. Prostate. 1994 Dec;25(6):310-9. doi: 10.1002/pros.2990250605. Prostate. 1994. PMID: 7997435

4

Androgen receptor: an overview.

Chang C, Saltzman A, Yeh S, Young W, Keller E, Lee HJ, Wang C, Mizokami A. Chang C, et al. Among authors: mizokami a. Crit Rev Eukaryot Gene Expr. 1995;5(2):97-125. doi: 10.1615/critreveukargeneexpr.v5.i2.10. Crit Rev Eukaryot Gene Expr. 1995. PMID: 8845584 Review.

5

Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line.

Mizokami A, Gotoh A, Yamada H, Keller ET, Matsumoto T. Mizokami A, et al. J Urol. 2000 Sep;164(3 Pt 1):800-5. doi: 10.1097/00005392-200009010-00053. J Urol. 2000. PMID: 10953159

6

Long-term exposure of tumor necrosis factor alpha causes hypersensitivity to androgen and anti-androgen withdrawal phenomenon in LNCaP prostate cancer cells.

Harada S, Keller ET, Fujimoto N, Koshida K, Namiki M, Matsumoto T, Mizokami A. Harada S, et al. Among authors: mizokami a. Prostate. 2001 Mar 1;46(4):319-26. doi: 10.1002/1097-0045(20010301)46:4<319::aid-pros1039>3.0.co;2-c. Prostate. 2001. PMID: 11241555

7

Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone.

Zhang J, Dai J, Qi Y, Lin DL, Smith P, Strayhorn C, Mizokami A, Fu Z, Westman J, Keller ET. Zhang J, et al. Among authors: mizokami a. J Clin Invest. 2001 May;107(10):1235-44. doi: 10.1172/JCI11685. J Clin Invest. 2001. PMID: 11375413 Free PMC article.

8

Different expression of androgen receptor coactivators in human prostate.

Fujimoto N, Mizokami A, Harada S, Matsumoto T. Fujimoto N, et al. Among authors: mizokami a. Urology. 2001 Aug;58(2):289-94. doi: 10.1016/s0090-4295(01)01117-7. Urology. 2001. PMID: 11489729

9

[Prospects for molecular research in urological oncology: bladder cancer].

Koshida K, Imao T, Ito H, Miyagi T, Konaka H, Mizokami A, Egawa M, Namiki M. Koshida K, et al. Among authors: mizokami a. Hinyokika Kiyo. 2001 Nov;47(11):815-8. Hinyokika Kiyo. 2001. PMID: 11771177 Free article. Japanese.

10

High-dose chemotherapy with peripheral blood stem cell transplantation for advanced testicular cancer.

Koshida K, Kato H, Mizokami A, Morishita H, Seto C, Komatsu K, Kou E, Uchibayashi T, Shiobara S, Namiki M. Koshida K, et al. Among authors: mizokami a. Int J Urol. 2002 Mar;9(3):146-53. doi: 10.1046/j.1442-2042.2002.00438.x. Int J Urol. 2002. PMID: 12010324 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

498 results

Search Page

Filters